Merck KGaA (MKGAF)
169.65
+2.53
(+1.51%)
USD |
OTCM |
Nov 16, 16:00
Merck Enterprise Value : 83.71B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 83.71B |
| November 13, 2026 | 82.61B |
| November 12, 2026 | 81.62B |
| November 11, 2026 | 83.88B |
| November 10, 2026 | 83.48B |
| November 09, 2026 | 83.90B |
| November 06, 2026 | 82.61B |
| November 05, 2026 | 83.81B |
| November 04, 2026 | 82.80B |
| November 03, 2026 | 82.75B |
| November 02, 2026 | 83.61B |
| October 30, 2026 | 83.53B |
| October 29, 2026 | 83.52B |
| October 28, 2026 | 82.58B |
| October 27, 2026 | 78.96B |
| October 26, 2026 | 80.30B |
| October 23, 2026 | 80.27B |
| October 22, 2026 | 79.53B |
| October 21, 2026 | 80.93B |
| October 20, 2026 | 82.65B |
| October 19, 2026 | 78.63B |
| October 16, 2026 | 80.29B |
| October 15, 2026 | 77.88B |
| October 14, 2026 | 80.57B |
| October 13, 2026 | 80.03B |
| Date | Value |
|---|---|
| October 12, 2026 | 77.97B |
| October 09, 2026 | 79.84B |
| October 08, 2026 | 77.01B |
| October 07, 2026 | 78.69B |
| October 06, 2026 | 80.79B |
| October 05, 2026 | 77.53B |
| October 02, 2026 | 77.88B |
| October 01, 2026 | 75.04B |
| September 30, 2026 | 81.22B |
| September 29, 2026 | 83.24B |
| September 28, 2026 | 81.31B |
| September 25, 2026 | 81.29B |
| September 24, 2026 | 79.40B |
| September 23, 2026 | 77.44B |
| September 22, 2026 | 77.16B |
| September 21, 2026 | 78.79B |
| September 18, 2026 | 77.93B |
| September 17, 2026 | 77.32B |
| September 16, 2026 | 80.24B |
| September 15, 2026 | 78.01B |
| September 14, 2026 | 80.38B |
| September 11, 2026 | 79.01B |
| September 10, 2026 | 78.03B |
| September 09, 2026 | 80.31B |
| September 08, 2026 | 79.36B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| STRATEC SE | 1.900B |
| Sartorius AG | 16.73B |
| Petros Pharmaceuticals, Inc. | -3.362M |
| QIAGEN NV | 11.10B |
| Agilent Technologies, Inc. | 50.95B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 517.73M |
| Revenue (Quarterly) | 6.474B |
| Total Expenses (Quarterly) | 5.956B |
| EPS Diluted (Quarterly) | 1.191 |
| Gross Profit Margin (Quarterly) | 60.05% |
| Profit Margin (Quarterly) | 8.00% |
| Earnings Yield | 3.02% |
| Operating Earnings Yield | 6.57% |
| Normalized Earnings Yield | 3.640 |